UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 63

Sortiert nach

Proceedings from the First Onco Summit: LATAM Chapter, 19–20 May 2023, Rio de Janeiro, Brazil

Cancers, 2024-09, Vol.16 (17), p.3063

2024

Volltextzugriff (PDF)

MM-722 Lymphocyte Profiling in Newly Diagnosed Multiple Myeloma: First-Line Treatment with Cyclophosphamide Thalidomide, Dexamethasone, and Daratumumab

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S580-S580

2024

Volltextzugriff (PDF)

Lymphocyte Profiling in Newly Diagnosed Multiple Myeloma: First-Line Treatment with Cyclophosphamide, Thalidomide, Dexamethasone, and Daratumumab

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S246-S246

2024

Volltextzugriff (PDF)

Long-Term Safety and Effectiveness of Rituximab Biosimilar RTXM83: A Retrospective Extension Study in Brazilian Patients with Diffuse Large B-Cell Lymphoma

Oncology and therapy, 2024-09, Vol.12 (3), p.585-598

2024

Volltextzugriff (PDF)

Editorial: How often can we get the right diagnosis after bone marrow transplant in patients with abnormal liver function tests? Authors' reply

Alimentary pharmacology & therapeutics, 2024-03, Vol.59 (5), p.707-708

2024

Volltextzugriff (PDF)

Current Practices on Therapy of Acute Graft Versus Host Disease (aGVHD) in Latin America (LA): Interim Results of a WBMT Survey

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S330-S330

2024

Volltextzugriff (PDF)

Current Practices on Prophylaxis of Graft Versus Host Disease (GVHD) in Latin America (LA): Interim Results of a WBMT Survey

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S334-S334

2024

Volltextzugriff (PDF)

Comparative Outcomes for HLA-Matched Siblings, Mismatched, and Haploidentical Donors in Myelodisplastic Syndromes: Report from the Latin American Register

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S304-S304

2024

Volltextzugriff (PDF)

Variability in the perception of palliative care and end-of-life care among hematology professionals from the same reference center in Bahia, Brazil: A descriptive cross-sectional study

São Paulo medical journal, 2024-01, Vol.142 (4), p.e2023225-e2023225

2024

Volltextzugriff (PDF)

Hepatobiliary disease after bone marrow transplant: A cross‐sectional study of 377 patients

Alimentary pharmacology & therapeutics, 2024-01, Vol.59 (1), p.71-79

2024

Volltextzugriff (PDF)

Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability

Oncotarget, 2023-12, Vol.14 (1), p.977-994

2023

Volltextzugriff (PDF)

Characteristics of paroxysmal nocturnal hemoglobinuria patients in Brazil: A retrospective administrative claims database analysis of PNH patients in Brazilian public healthcare system

PloS one, 2023-07, Vol.18 (7), p.e0288708-e0288708

2023

Volltextzugriff (PDF)

10-year real-world data on acute myeloid leukemia: The paradigm of a public health center in Brazil

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e19022-e19022

2023

Volltextzugriff (PDF)

403 - In the Molecular Classification Era, Can We Still Use IPSS-R in HSCT of MDS Patients?

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S304-S305

2023

Volltextzugriff (PDF)

In the Molecular Classification Era, Can We Still Use IPSS-R in HSCT of MDS Patients?

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S304-S305

2023

Volltextzugriff (PDF)

Retrospective Observational Study of the Long-Term Safety and Efficacy Outcomes of Rituximab Biosimilar: Partial Data of RTXM83-AC-01-11 Subanalysis Study

Blood, 2022-11, Vol.140 (Supplement 1), p.13236-13238

2022

Volltextzugriff (PDF)

Variability in End-of-Life Care and Perception of Palliative Care Among Physicians in the Hematology Unit of a Reference Service in the State of Bahia, Brazil

Blood, 2022-11, Vol.140 (Supplement 1), p.13295-13296

2022

Volltextzugriff (PDF)

Daratumumab (Dara), Cyclophosphamide, Thalidomide and Dexamethasone for Transplant Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients: Response Rate Impacts on PFS

Blood, 2022-11, Vol.140 (Supplement 1), p.7699-7700

2022

Volltextzugriff (PDF)

Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies

European journal of haematology, 2022-09, Vol.109 (3), p.205-214

2022

Volltextzugriff (PDF)

Updated safety and efficacy data from an open-label, phase 1/2 study of frontline brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A+AVD) in pediatric patients with advanced-stage classical Hodgkin lymphoma (cHL)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.10000-10000

2022

Volltextzugriff (PDF)

COVID-19 in HSCT recipients: a collaborative study of the Brazilian Society of Marrow Transplantation (SBTMO)

Bone marrow transplantation (Basingstoke), 2022-03, Vol.57 (3), p.453-459

2022

Volltextzugriff (PDF)

Evaluation of Hematopoietic Stem Cell Product As a New Site for Minimal Residual Disease By Next Generation Flow in Multiple Myeloma

Blood, 2021-11, Vol.138 (Supplement 1), p.4927-4927

2021

Volltextzugriff (PDF)

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients

Hematology, Transfusion and Cell Therapy, 2021-11, Vol.43 (Suppl 2), p.S30-S34

2021

Volltextzugriff (PDF)

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. I: Structuring centers for the multidisciplinary clinical administration and management of CAR-T cell therapy patients

Hematology, Transfusion and Cell Therapy, 2021-11, Vol.43 (Suppl 2), p.S3-S12

2021

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Database Model

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(62)
Berichte
(1)

Sprache

Englisch
(60)
Portugiesisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Proceedings from the First Onco Summit: LATAM Chapter, 19–20 May 2023, Rio de Janeiro, Brazil

MM-722 Lymphocyte Profiling in Newly Diagnosed Multiple Myeloma: First-Line Treatment with Cyclophosphamide Thalidomide, Dexamethasone, and Daratumumab

Lymphocyte Profiling in Newly Diagnosed Multiple Myeloma: First-Line Treatment with Cyclophosphamide, Thalidomide, Dexamethasone, and Daratumumab

Long-Term Safety and Effectiveness of Rituximab Biosimilar RTXM83: A Retrospective Extension Study in Brazilian Patients with Diffuse Large B-Cell Lymphoma

Editorial: How often can we get the right diagnosis after bone marrow transplant in patients with abnormal liver function tests? Authors' reply

Current Practices on Therapy of Acute Graft Versus Host Disease (aGVHD) in Latin America (LA): Interim Results of a WBMT Survey

Current Practices on Prophylaxis of Graft Versus Host Disease (GVHD) in Latin America (LA): Interim Results of a WBMT Survey

Comparative Outcomes for HLA-Matched Siblings, Mismatched, and Haploidentical Donors in Myelodisplastic Syndromes: Report from the Latin American Register

Variability in the perception of palliative care and end-of-life care among hematology professionals from the same reference center in Bahia, Brazil: A descriptive cross-sectional study

Hepatobiliary disease after bone marrow transplant: A cross‐sectional study of 377 patients

Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability

Characteristics of paroxysmal nocturnal hemoglobinuria patients in Brazil: A retrospective administrative claims database analysis of PNH patients in Brazilian public healthcare system

10-year real-world data on acute myeloid leukemia: The paradigm of a public health center in Brazil

403 - In the Molecular Classification Era, Can We Still Use IPSS-R in HSCT of MDS Patients?

In the Molecular Classification Era, Can We Still Use IPSS-R in HSCT of MDS Patients?

Retrospective Observational Study of the Long-Term Safety and Efficacy Outcomes of Rituximab Biosimilar: Partial Data of RTXM83-AC-01-11 Subanalysis Study

Variability in End-of-Life Care and Perception of Palliative Care Among Physicians in the Hematology Unit of a Reference Service in the State of Bahia, Brazil

Daratumumab (Dara), Cyclophosphamide, Thalidomide and Dexamethasone for Transplant Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients: Response Rate Impacts on PFS

Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies

Updated safety and efficacy data from an open-label, phase 1/2 study of frontline brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A+AVD) in pediatric patients with advanced-stage classical Hodgkin lymphoma (cHL)

COVID-19 in HSCT recipients: a collaborative study of the Brazilian Society of Marrow Transplantation (SBTMO)

Evaluation of Hematopoietic Stem Cell Product As a New Site for Minimal Residual Disease By Next Generation Flow in Multiple Myeloma

Progression Free Survival (PFS) Analysis of Daratumumab (Dara), Cyclophosphamide, Thalidomide and Dexamethasone: A Quadruplet Intensified Treatment for Transplant Eligible Newly Diagnosed Multiple Myeloma (TE NDMM) Patients

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. IV: CAR-T cell therapy for multiple myeloma patients

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. I: Structuring centers for the multidisciplinary clinical administration and management of CAR-T cell therapy patients

Aktive Filter

Suchergebnisse filtern